Home Cart Sign in  
Chemical Structure| 1227911-45-6 Chemical Structure| 1227911-45-6

Structure of GSK2334470
CAS No.: 1227911-45-6

Chemical Structure| 1227911-45-6

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

GSK2334470 is a PDK1 inhibitor with IC50 of ~10 nM, with no activity at other close related AGC-kinases.

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of GSK2334470

CAS No. :1227911-45-6
Formula : C25H34N8O
M.W : 462.59
SMILES Code : O=C([C@@H]1CN(C2=NC(NC)=NC(C3=CC4=C(C=C3)C(N)=NN4)=C2)[C@H](C)CC1)NC5CCCCC5
MDL No. :MFCD21608525
InChI Key :QLPHOXTXAKOFMU-WBVHZDCISA-N
Pubchem ID :46215815

Safety of GSK2334470

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302
Precautionary Statements:P280-P305+P351+P338

Related Pathways of GSK2334470

PI3K-AKT

Isoform Comparison

Biological Activity

Target
  • PDK1

    PDK-1, IC50:10 nM

In Vitro:

Cell Line
Concentration Treated Time Description References
ER+ breast cancer cell lines 1 μM 72 h to synergistically inhibit proliferation and increase apoptosis PMC5421398
CD4 T cells 2.5 mM 3 days GSK significantly attenuated HS-induced phosphorylation of PDPK1 and SGK1, and corrected the Th17 enhancement and Treg impediment triggered by HS PMC11214488
CD4 T cells 5 mM, 10 mM 3 days GSK significantly increased CD4 T cell apoptosis and inhibited their proliferation PMC11214488
LAN-1-MK cells 5 µM 72 hours GSK2334470 significantly inhibited the growth of LAN-1-MK cells and induced G0-G1 phase cell accumulation. PMC4587771
KP-N-SIFA-MK cells 5 µM 72 hours GSK2334470 significantly inhibited the growth of KP-N-SIFA-MK cells and induced G0-G1 phase cell accumulation. PMC4587771
SK-N-DZ-MK cells 5 µM 72 hours GSK2334470 significantly inhibited the growth of SK-N-DZ-MK cells and induced G0-G1 phase cell accumulation. PMC4587771

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Mice MCF-7 xenograft model Intraperitoneal injection 100 mg/kg three times per week for 6 weeks to determine the efficacy in decreasing tumor growth PMC5421398
DBA/1 mice Collagen-induced arthritis model Intraperitoneal injection 25 mg/kg Every three days for 21 days GSK significantly alleviated HS diet-exacerbated arthritis symptoms and corrected the Th17/Treg imbalance PMC11214488

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.16mL

0.43mL

0.22mL

10.81mL

2.16mL

1.08mL

21.62mL

4.32mL

2.16mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories